These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21625540)

  • 21. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation.
    Al-Ramahi I; Lam YC; Chen HK; de Gouyon B; Zhang M; Pérez AM; Branco J; de Haro M; Patterson C; Zoghbi HY; Botas J
    J Biol Chem; 2006 Sep; 281(36):26714-24. PubMed ID: 16831871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The type II deiodinase is retrotranslocated to the cytoplasm and proteasomes via p97/Atx3 complex.
    Arrojo E Drigo R; Egri P; Jo S; Gereben B; Bianco AC
    Mol Endocrinol; 2013 Dec; 27(12):2105-15. PubMed ID: 24196352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.
    Cummings CJ; Mancini MA; Antalffy B; DeFranco DB; Orr HT; Zoghbi HY
    Nat Genet; 1998 Jun; 19(2):148-54. PubMed ID: 9620770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling.
    Demand J; Alberti S; Patterson C; Höhfeld J
    Curr Biol; 2001 Oct; 11(20):1569-77. PubMed ID: 11676916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclase.
    Xia T; Dimitropoulou C; Zeng J; Antonova GN; Snead C; Venema RC; Fulton D; Qian S; Patterson C; Papapetropoulos A; Catravas JD
    Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H3080-7. PubMed ID: 17873020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHIP and HSPs interact with beta-APP in a proteasome-dependent manner and influence Abeta metabolism.
    Kumar P; Ambasta RK; Veereshwarayya V; Rosen KM; Kosik KS; Band H; Mestril R; Patterson C; Querfurth HW
    Hum Mol Genet; 2007 Apr; 16(7):848-64. PubMed ID: 17317785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chaperoning proteins for destruction: diverse roles of Hsp70 chaperones and their co-chaperones in targeting misfolded proteins to the proteasome.
    Shiber A; Ravid T
    Biomolecules; 2014 Jul; 4(3):704-24. PubMed ID: 25036888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CHIP: a co-chaperone for degradation by the proteasome.
    Edkins AL
    Subcell Biochem; 2015; 78():219-42. PubMed ID: 25487024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The extent of Ssa1/Ssa2 Hsp70 chaperone involvement in nuclear protein quality control degradation varies with the substrate.
    Jones RD; Enam C; Ibarra R; Borror HR; Mostoller KE; Fredrickson EK; Lin J; Chuang E; March Z; Shorter J; Ravid T; Kleiger G; Gardner RG
    Mol Biol Cell; 2020 Feb; 31(3):221-233. PubMed ID: 31825716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology.
    Yang H; Li JJ; Liu S; Zhao J; Jiang YJ; Song AX; Hu HY
    Sci Rep; 2014 Sep; 4():6410. PubMed ID: 25231079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis.
    Doss-Pepe EW; Stenroos ES; Johnson WG; Madura K
    Mol Cell Biol; 2003 Sep; 23(18):6469-83. PubMed ID: 12944474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome.
    Wang H; Jia N; Fei E; Wang Z; Liu C; Zhang T; Fan J; Wu M; Chen L; Nukina N; Zhou J; Wang G
    J Neurochem; 2007 Jun; 101(6):1651-61. PubMed ID: 17302910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsp40 Molecules That Target to the Ubiquitin-proteasome System Decrease Inclusion Formation in Models of Polyglutamine Disease.
    Howarth JL; Kelly S; Keasey MP; Glover C; Lee YB; Mitrophanous K; Chapple JP; Gallo JM; Cheetham ME; Uney JB
    Mol Ther; 2007 Jun; 15(6):1100-1105. PubMed ID: 28182921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heat shock protein 70 together with its co-chaperone CHIP inhibits TNF-alpha induced apoptosis by promoting proteasomal degradation of apoptosis signal-regulating kinase1.
    Gao Y; Han C; Huang H; Xin Y; Xu Y; Luo L; Yin Z
    Apoptosis; 2010 Jul; 15(7):822-33. PubMed ID: 20349136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3.
    Nicastro G; Todi SV; Karaca E; Bonvin AM; Paulson HL; Pastore A
    PLoS One; 2010 Aug; 5(8):e12430. PubMed ID: 20865150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleocytoplasmic shuttling activity of ataxin-3.
    Macedo-Ribeiro S; Cortes L; Maciel P; Carvalho AL
    PLoS One; 2009 Jun; 4(6):e5834. PubMed ID: 19503814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation.
    Ahmed SF; Deb S; Paul I; Chatterjee A; Mandal T; Chatterjee U; Ghosh MK
    J Biol Chem; 2012 May; 287(19):15996-6006. PubMed ID: 22427670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory inter-domain interactions influence Hsp70 recruitment to the DnaJB8 chaperone.
    Ryder BD; Matlahov I; Bali S; Vaquer-Alicea J; van der Wel PCA; Joachimiak LA
    Nat Commun; 2021 Feb; 12(1):946. PubMed ID: 33574241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of 70-kDa heat-shock-protein ATPase activity and substrate binding by human DnaJ-like proteins, HSJ1a and HSJ1b.
    Cheetham ME; Jackson AP; Anderton BH
    Eur J Biochem; 1994 Nov; 226(1):99-107. PubMed ID: 7957263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.